Case study: automating cell-based assays to determine viral vector titer
![](https://www.bioanalysis-zone.com/wp-content/uploads/2023/06/BZ-2023-Q3-Hamilton-IF-cell-based-case-study-SMfeature-800x345.png)
In this case study, Oxford Biomedica (Oxford, UK), an innovative global gene and cell therapy company with operations in the UK and US, describes the automation of a 10 day cell-based workflow required for an analytical test to determine viral vector titer, using Hamilton Microlab® STARTM liquid handlers.
Highlights of this case study include:
- Detailed description of the automated system used for the cell-based workflow
- Advantages of Hamilton’s CECULA Graphical User Interface (GUI) for the planning of long-term cell-based assays
- Transfer of the automated assay to Good Manufacturing Practice (GMP)
In association with